Ozempic vs Wegovy: Differences, Doses, Cost and Results

Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Ozempic vs Wegovy is mostly a question of approval, because both contain the same drug. Both are semaglutide from Novo Nordisk, but the Ozempic label approves it for type 2 diabetes, while the Wegovy label approves it for weight reduction, heart event risk and a liver condition. The practical choice is which one matches your diagnosis, your prescription and your budget.

Table of Contents

Is Ozempic the Same as Wegovy?

They share the active ingredient but not the label. Both the Ozempic label and the Wegovy label name semaglutide, a GLP-1 receptor agonist, as the active drug. The Wegovy label’s limitations of use say taking it with other semaglutide products or any other GLP-1 receptor agonist is not recommended, so people take one or the other.

I’m Judy, and I’m not a doctor or a registered dietitian. Below I stay with the two FDA labels, published trials and the maker’s own pages. My own GLP-1 story is in my GLP-1 weight loss story, and it’s one woman’s account, not medical advice.

How Do Ozempic and Wegovy Work?

The Wegovy label says GLP-1 is a regulator of appetite and calorie intake, and that GLP-1 receptors sit in brain areas involved in appetite. The Ozempic label describes its blood sugar effect differently: semaglutide stimulates insulin release when blood glucose is high and lowers glucagon, with a minor delay in stomach emptying after meals. It is the same molecule, and the labels simply describe the effects that matter for each approved use.

What Is the Difference Between Ozempic and Wegovy?

The differences are the approved uses, the top dose, the pill versions and the self-pay price. Each row below is explained with its source in the sections that follow.

	Ozempic	Wegovy
Approved use	Type 2 diabetes, heart event risk and kidney outcomes in type 2 diabetes	Weight reduction, heart event risk, and a liver condition called MASH
Top weekly injection dose	2 mg	2.4 mg, or 7.2 mg as Wegovy HD
Daily tablet	Ozempic tablets, 1.5 mg start, 4 mg or 9 mg after	Wegovy tablets, 1.5 mg start, 25 mg maintenance
Self-pay injection price, read October 14, 2026	$199 for the first two fills for new patients, then $349 up to 1 mg and $499 for 2 mg	$199 for the first two fills for new patients, then $349 up to 2.4 mg and $399 for 7.2 mg

What Is Ozempic Approved For in Type 2 Diabetes?

The Ozempic label approves the injection, alongside diet and exercise, to improve blood sugar in adults with type 2 diabetes. It also approves it to lower the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease, and to lower the risk of kidney decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. Weight loss is not one of its labelled uses. The Ozempic tablets label covers blood sugar control in adults with type 2 diabetes and lower cardiovascular risk in those at high risk.

What Is Wegovy Approved For?

The Wegovy label approves the injection, alongside a reduced calorie diet and more physical activity, to lower cardiovascular risk in adults with established heart disease and either obesity or overweight. It also approves it to reduce excess body weight and keep it off in adults and children 12 and older with obesity, and in adults with overweight and at least one weight-related condition. A third indication is noncirrhotic MASH with moderate to advanced liver fibrosis in adults, which the label says rests on accelerated approval. The Wegovy tablets carry the heart and weight indications for adults.

How Do the Ozempic and Wegovy Doses Compare?

Per the Ozempic label, the dose starts at 0.25 mg once a week for 4 weeks, moves to 0.5 mg, and the maintenance dose is 0.5, 1 or 2 mg, with 2 mg the maximum. Per the Wegovy label, it starts at 0.25 mg and steps up every 4 weeks through 0.5, 1 and 1.7 mg to a maintenance dose of 1.7 mg or 2.4 mg, with 2.4 mg recommended. After at least 4 weeks on 2.4 mg, the label lets a prescriber go up to 7.2 mg when more weight reduction is clinically indicated, and that dose is sold as Wegovy HD.

Ozempic vs Wegovy for Weight Loss: Which Is Better?

Wegovy is the one tested and approved for weight loss, so it is the label-matched choice when weight is the goal. In the Wegovy label’s Study 2, also published as the STEP 1 trial, adults with obesity, or overweight plus a weight-related condition, and without diabetes lost an average of 14.9% of body weight over 68 weeks on 2.4 mg, against 2.4% on placebo. The label gives that group’s mean age as 46, and 74% were female.

Ozempic was tested for blood sugar in adults with type 2 diabetes, and its label reports body weight only as a side measurement. Do not line the two sets of numbers up, because the people and the doses differ.

How Much Weight Do People Lose on Wegovy?

Diabetes changes the answer. In the Wegovy label’s trial of adults with type 2 diabetes and a BMI of 27 or more, the average loss at 68 weeks was 9.6% on 2.4 mg versus 3.4% on placebo. For the daily tablet, the label’s 64 week trial in adults without diabetes shows 13.6% on the 25 mg tablet versus 2.4% on placebo. Averages hide a lot of individual variation.

How Much Weight Do People Lose on Ozempic?

The Ozempic label reports weight in kilograms, in people with type 2 diabetes. In its 40 week trial, the average change was 5.6 kg on 1 mg and 6.4 kg on 2 mg, and the label calls the difference between those two arms not statistically significant. In a 30 week trial of Ozempic alone it was 3.8 kg on 0.5 mg and 4.7 kg on 1 mg, versus 1.2 kg on placebo.

Does a Higher Dose Mean More Weight Loss?

In the Wegovy label’s trials, the 7.2 mg dose averaged more loss than 2.4 mg. In its 72 week Study 8, adults with obesity and no diabetes lost an average of 18.8% on 7.2 mg, 15.5% on 2.4 mg and 3.9% on placebo. In Study 9, adults with obesity and type 2 diabetes lost 13.2%, 10.4% and 3.8%. In Study 8, 5.4% of people on 7.2 mg permanently stopped because of adverse reactions, against 1% on placebo. Ask your prescriber about side effects at each dose, because a higher dose is not automatically the better one for you.

How Does My Own Weight Loss Compare With the Trials?

This is my experience, not medical advice. I started GLP-1 injections in May 2024 at age 47, about 68 pounds overweight, and lost 31 pounds in 14 months, as I say on my about page. The typical result in STEP 1 was a 14.9% loss over 68 weeks. A trial average and one woman’s result are not the same thing, and results vary a lot from person to person. My story with the trial numbers beside it is in Wegovy before and after results in women.

Can a Doctor Prescribe Ozempic for Weight Loss?

A doctor can, but that is off-label use, which means the weight claim is not on Ozempic’s label. The FDA says that once it approves a drug, healthcare providers generally may prescribe it for an unapproved use when they judge it medically appropriate for the patient. The NIDDK adds that you should feel comfortable asking whether your provider is prescribing a medication that is not approved for overweight or obesity.

Who Qualifies for Wegovy?

The label wording is adults with obesity, or overweight with at least one weight-related condition, and children 12 and older with obesity. The NIDDK says weight management medications may be prescribed for an adult BMI of 30 or greater, or 27 or greater with weight-related health problems such as high blood pressure or type 2 diabetes. It also says these medications are not for everyone with a high BMI, and that they do not replace physical activity and healthy eating habits.

Which Has Worse Side Effects, Ozempic or Wegovy?

They cause the same kinds of effects, mostly digestive, and the two labels do not allow a clean head to head. In the Wegovy label’s adult weight reduction trials, the most common side effects were nausea in 44% of people on Wegovy versus 16% on placebo, vomiting at 24% versus 6%, and diarrhea at 30% versus 16%. In the Ozempic label’s diabetes trials, the most common side effect was also nausea, at about 16% on 0.5 mg and 20% on 1 mg versus 6% on placebo.

The people and doses differ, so I would not choose on those rates alone. Both labels carry a boxed warning about thyroid C-cell tumors in rodents, and say it is unknown whether semaglutide causes them in humans. Both also warn about pancreatitis, gallbladder disease, severe digestive reactions and kidney injury from dehydration. The signs to call your prescriber about are in Ozempic side effects.

Who Should Not Take Ozempic or Wegovy?

Both labels list a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 as a contraindication, along with a prior serious allergic reaction to semaglutide. The Wegovy label says weight loss offers no benefit to a pregnant patient and may cause fetal harm, and to stop it in pregnant patients using it for weight reduction. The Ozempic label says to use it in pregnancy only if the benefit justifies the risk to the fetus. For people with type 2 diabetes, both labels also carry a diabetic retinopathy warning, and both warn of a higher low blood sugar risk when it is combined with insulin or a sulfonylurea.

Do Ozempic and Wegovy Lower Cardiovascular Risk?

Each label carries a heart indication for a specific group. Ozempic’s covers adults with type 2 diabetes and established heart disease. Wegovy’s covers adults with established heart disease and either obesity or overweight, and in that label’s cardiovascular outcomes trial, Wegovy lowered the risk of a first major cardiovascular event, with a hazard ratio of 0.80 (95% confidence interval 0.72 to 0.90). Your own health history decides which label could apply to you, so ask your doctor before assuming either medication lowers your risk.

How Much Do Ozempic and Wegovy Cost?

On October 14, 2026, the Ozempic savings page listed self-pay at $199 a month for new patients’ first two fills of 0.25 mg and 0.5 mg, then $349 a month for 0.25, 0.5 or 1 mg and $499 for 2 mg. The NovoCare Wegovy page listed the same $199 start, then $349 a month from 0.25 mg up to 2.4 mg and $399 for Wegovy HD at 7.2 mg. Both pages say the $199 offer is for two monthly fills and runs through December 31, 2026, and that Novo Nordisk can change or cancel its programs. The numbers behind those prices are in how much Ozempic costs.

Does Insurance Cover Ozempic or Wegovy?

It depends on your plan. The NIDDK says some, but not all, insurance plans cover weight management medications. The Ozempic savings page says coverage depends on your plan’s formulary, the FDA-approved indication and any prior authorization or step therapy rules, and that self-pay purchases do not count toward your deductible. Both Novo Nordisk pages list a pay-as-little-as-$25 offer for commercially insured patients whose plan covers the drug, with eligibility limits. Call your insurer before the first fill.

How Do Mounjaro and Zepbound Compare With These Medications?

Mounjaro and Zepbound both contain tirzepatide from Eli Lilly, according to the DailyMed records for Mounjaro and Zepbound. The trial report calls tirzepatide a GIP and GLP-1 receptor agonist. In the SURMOUNT-1 trial of 2,539 adults with obesity, or overweight plus a weight-related condition, and no diabetes, people on 5, 10 and 15 mg lost an average of 15.0%, 19.5% and 20.9% over 72 weeks, versus 3.1% on placebo.

In the SURMOUNT-5 trial, a head to head study of 751 adults with obesity and no diabetes, tirzepatide produced a 20.2% average loss against 13.7% for semaglutide at the maximum tolerated dose. It was open-label and funded by Eli Lilly, so read it with that in mind. Averages hide individual variation, and the choice between drugs belongs to you and your prescriber.

Which Should You Ask Your Doctor About?

Bring your health history, current weight, goal weight, current medications and your goals, and ask for the medical reason behind the choice. If you have type 2 diabetes, Ozempic is the version approved for it. If you want weight management and do not have diabetes, Wegovy is the version approved for that, and a prescriber may still weigh other options. The NIDDK also notes you will probably regain some weight after stopping a weight management medication, so ask what the plan is for when you stop.

If you decide to try telehealth, a licensed clinician decides whether a medication is right for you, and I explain the steps in how to get GLP-1 online. On October 14, 2026, the ShedRX page I link to listed Wegovy pens and compounded semaglutide injections, and I may earn a commission if you sign up through that link. GobyMeds is another option, covered in my GobyMeds review. Its sign-up page says treatments are prescribed by licensed healthcare professionals after a consultation, and that pricing and availability can differ by location. GobyMeds uses one general registration page for all of its products, so this link opens an account sign-up, not a page about one treatment. After you create an account, you can start a consultation for the treatment you want.

Ask any provider whether you are getting a brand-name or a compounded medication. The FDA says unapproved versions do not go through its review for safety, effectiveness and quality, and that compounded drugs should only be used when a patient’s needs cannot be met by an approved drug.

Medical disclaimer: I’m a woman who has used a GLP-1, not a clinician, and this page is a reading of public labels and trials, not advice about your body. Talk with your prescriber about side effects, your weight management options and whether to start, switch, change the dose of or stop any medication, including the two on this page.

For the full picture, start with my overview of GLP-1 weight loss.

Frequently Asked Questions

Can you take Ozempic and Wegovy together?

No. The Wegovy label says using it with other semaglutide products or any other GLP-1 receptor agonist is not recommended. Both products are semaglutide, so taking both would only double up on the same drug.

Is the Wegovy pill the same as the Ozempic pill?

No. Both are semaglutide tablets from Novo Nordisk, but the labels differ. The Wegovy tablet starts at 1.5 mg and reaches a 25 mg maintenance dose, and is approved for weight reduction and heart event risk in adults. The Ozempic tablets start at 1.5 mg and go to 4 mg or 9 mg, and are approved for type 2 diabetes and for heart event risk in type 2 diabetes.

Why is Wegovy approved for weight loss but Ozempic is not?

Because each was tested for a different purpose. Wegovy was studied at higher doses in people with obesity or overweight, and Ozempic was studied for blood sugar in people with type 2 diabetes. The FDA approves a drug for the uses its trials support, so the same active ingredient can carry different indications.

Can you switch from Ozempic to Wegovy?

Your prescriber decides that. The Wegovy label starts its dosing at 0.25 mg and steps up every four weeks, so the schedule is not the same as an Ozempic schedule. Do not switch on your own, and do not use leftover pens from a different prescription.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. The FDA says unapproved versions of semaglutide do not go through its review for safety, effectiveness and quality, and lists claims that a compounded drug is the same as an approved drug as a telehealth red flag. Ask which product you would receive before you pay.

Which costs less, Ozempic or Wegovy?

At the maker’s self-pay prices read on October 14, 2026, the two start at the same $199 for new patients’ first two fills. Afterward Ozempic is $349 up to 1 mg and $499 at 2 mg, and Wegovy is $349 up to 2.4 mg and $399 at 7.2 mg. They are different products at different doses, so compare your own prescribed dose and your insurance before judging.

Sources

Ozempic vs Wegovy for Weight Loss: What Is the Difference?